603073.Ss
603073.SS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.
Business. 603073.SS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
603073.SS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.
The company maintains a strong liquidity position, with a current ratio of 3.09, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, the free cash flow is negative at -84.75 million CNY, which suggests that the company is spending more on capital expenditures than it is generating in operating cash flow. The debt-to-equity ratio is 0.06, indicating a relatively low level of leverage and a conservative capital structure.
In terms of profitability, the company's return on equity (ROE) is 5.04%, and its return on assets (ROA) is 4.2%. These figures are below the typical thresholds for high-performing specialty chemicals firms, suggesting that the company is not generating returns as efficiently as its peers. The gross profit margin is 24.42%, and the operating margin is 10.17%, which are both in line with the industry average for specialty chemicals.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's revenue is primarily derived from the sale of chemical products, with no significant diversification into other product lines or services.
The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The company's capital expenditures are substantial, at -179.85 million CNY, which may indicate a focus on long-term expansion or modernization of facilities. However, the negative free cash flow suggests that the company is not currently generating enough cash to sustain this level of investment without external financing.
The company faces a medium liquidity risk due to its negative net cash position after subtracting total debt. This could limit its ability to fund operations or respond to unexpected financial needs without additional financing. The dilution risk is low, as the company has not issued additional shares recently, and the number of shares outstanding has remained stable.
Recent events include the company's continued investment in capital expenditures, which may signal a strategic focus on long-term growth. However, the negative free cash flow indicates that the company is not currently generating enough cash to support these investments without external financing. No significant regulatory or geopolitical events have been reported that would directly impact the company's operations.
- The company has a strong current ratio but a negative free cash flow, indicating potential liquidity constraints.
- The company's ROE and ROA are below industry benchmarks, suggesting inefficiencies in capital utilization.
- The company's revenue is concentrated in a single business segment, increasing its exposure to market volatility.
- The company is investing heavily in capital expenditures, which may support long-term growth but is currently funded by negative free cash flow.
- The company's debt-to-equity ratio is low, indicating a conservative capital structure.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 603073.SS Market data — financials · 2026-05-27